Biopharmaceuticals: the economic equation
- PMID: 22478688
- PMCID: PMC2651729
Biopharmaceuticals: the economic equation
Abstract
As more biopharmaceuticals reach the market, more attention will be given to issues such as cost-effectiveness evaluations, biosimilars, and price controls. The value biologic therapies bring to the healthcare system may take years to appreciate in full -perhaps only when policy decisions allow for their economic effects to be understood.
Figures
References
-
- Berenson A. Costly cancer drugs bring hard decisions. International Herald Tribune. July 13. 2005. [Accessed Nov. 16, 2007]. « http://www.iht.com/articles/2005/07/12/business/drugs.php.».
-
- Biotechnology. Standard and Poor’s Industry Surveys. 2006;174:1–51.
-
- Carino T, Williams RD, II, Colbert AM, Bridges P. Medicare’s coverage of colorectal cancer drugs: a case study in evidence development and policy. Health Aff. 2006;25:1231–1239. - PubMed
-
- Economic Report of the President transmitted to Congress. Washington: Government Printing Office; Feb, 2007. 2007.
LinkOut - more resources
Full Text Sources
Research Materials